Appointments add deep dermatology drug development and commercialization expertise as Amplifica advances its hair-growth pipeline SAN DIEGO, CA –

Oversubscribed round with proceeds to support continued clinical development SAN DIEGO, CA - Amplifica Holdings Group, Inc. (“Amplifica”), a

Poster Highlights First-in-Human Results for the Treatment of Androgenetic AlopeciaSan Diego, CA, May 7, 2025 – Amplifica Holdings Group Inc.

First-in-Human Trial Demonstrates Promising Results for the Treatment of Androgenetic Alopecia San Diego, CA, September 30, 2024 - Amplifica

Amplifica’s AMP-303 safety and tolerability study targeting hair loss SAN DIEGO, CA., June 28, 2023 - Amplifica Holdings Group,

Exclusive Licensing Agreement Allows for Access to Promising Early-Stage ProteinSAN DIEGO, CA., January 26, 2023 - Amplifica Holdings Group, Inc.

SAN DIEGO, CA - Amplifica Holdings Group, Inc. (“Amplifica”), a privately-held, clinical-stage biopharmaceutical company announced it successfully closed an